The pandemic influenza vaccination coverage in children with type 1 diabetes has been analyzed. 1,461 charts have been reviewed (788 M and 673 F, ages 13.0 ± 4.1 y, disease duration 6.0 ± 4.8 y, HbA1c 7.9 ± 1.2%). Among them, 428 patients (29.3%) underwent A/H1N1 vaccination. A special effort is required to implement an increased immunization rate.
Pandemic influenza vaccination coverage in children with type 1 diabetes : analysis from seven Italian centers / I. Rabbone, A.E. Scaramuzza, D. Iafusco, R. Bonfanti, F. Lombardo, V. Cherubini, S. Toni, F. Cerutti, G.V. Zuccotti. - In: HUMAN VACCINES. - ISSN 1554-8600. - 7:12(2011 Dec), pp. 1291-1292.
Pandemic influenza vaccination coverage in children with type 1 diabetes : analysis from seven Italian centers
R. Bonfanti;G.V. ZuccottiUltimo
2011
Abstract
The pandemic influenza vaccination coverage in children with type 1 diabetes has been analyzed. 1,461 charts have been reviewed (788 M and 673 F, ages 13.0 ± 4.1 y, disease duration 6.0 ± 4.8 y, HbA1c 7.9 ± 1.2%). Among them, 428 patients (29.3%) underwent A/H1N1 vaccination. A special effort is required to implement an increased immunization rate.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
